The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vorob'eva O.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ

Thioctic (alpha-lipoic) acid-spectrum of clinical use

Authors:

Vorob'eva O.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(10): 86‑90

Read: 20601 times

Download PDF (RU)
Contact the author
Table of contents

THIOCTIC (ALPHA-LIPOIC) ACID-SPECTRUM OF CLINICAL USE
THIOCTIC (ALPHA-LIPOIC) ACID-SPECTRUM OF CLINICAL USE

To cite this article:

Vorob'eva OV. Thioctic (alpha-lipoic) acid-spectrum of clinical use. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(10):86‑90. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Keywords:

thioctic (alpha-lipoic) acid
clinical use

Authors:

Vorob'eva O.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ

Close metadata

References:

  1. Artamonova V.G. Lashina E.L. Primenenie preparata tiolepta (tioktovaya kislota), v kombinirovannoi terapii vibratsionnoi bolezni. Zhurn nevrol i psikhiat 2011; 111: 1: 82-85.
  2. Barantsevich E.R., Posokhina O.V. Podkhody k terapii nevrologicheskikh proyavlenii sakharnogo diabeta. Zhurnal nevrol i psikhiat 2010; 110: 4: 63-66.
  3. Kovrazhkina E.A., Airiyan N.Yu., Serkin G.V. i dr. Vozmozhnosti i perspektivy primeneniya berlitiona dlya lecheniya alkogol'noi polinevropatii. Zhurn nevrol i psikhiat 2004; 104: 2: 33-37.
  4. Sklyar I.A., Vorob'eva O.V., Sharyapova R.B., Sadekov R.K. Tioktatsid v lechenii alkogol'noi polinevropatii. Lechenie nervnykh boleznei 2001; 2: 39-41.
  5. Strokov I.A., Akhmetzhanova L.T., Solokha O.A. Effektivnost' lecheniya diabeticheskoi polinevropatii tabletirovannoi formoi al'fa-lipoevoi kisloty. Trudnyi patsient 2010; 8: 3: 17-21.
  6. Al-Majed A.A., Gado A.M., Al-Shabanah O.A., Mansour A.M. Alpha-lipoic Acid Ameliorates Myocardial Toxicity Induced by Doxorubicin. Pharmacol Res December 2002; 46: 6: 499-503.
  7. Ametov A.S., Barinov A., Dyck P.J. et al. SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26: 770-776.
  8. Baur A. et al. Alpha lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr 1991: 69: 722-724.
  9. Biewenga G.P., Haenen G.R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.
  10. Cao X., Phillis J.W. Free Radical Research 1995; 23: 365.
  11. Coppey L.J., Gellett J.S., Davidson E.P. et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001; 50: 1927-1937.
  12. Gedlicka C., Kornek G.V., Schmid K., Scheithauer W. Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid. Annals of Oncology 2003; 14: 339-340.
  13. Han D., Tritschler H.J., Packer L. Alpha-lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 1995; 6: 207: 1: 258-264.
  14. Hummel T., Heilmann S., Huttenbriuk K.B. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope 2002; 112: 11: 2076-2080.
  15. Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Experimental Neurology 1995; 132: 180-185.
  16. Kowluru R.A. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 2005; 14: 76: 9: 1051-1060.
  17. Logan A.C., Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Alternative Medicine Review 2001; 6: 5: 450-459.
  18. Marracci G.H., Jones R.E., McKeon G.P., Bourdette D.N. Alpha Lipoic Acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. Journal of Neuroimmunololgy 2002; 131: 1-2: 104-114.
  19. Miinea C., Eichberg J. Antioxidant protection mechanisms and arachidonic acid synthesis are altered in Schwann cells grown in elevated glucose. Fifth Diabetic Neuropathy Satellite Symposium 2000; 32.
  20. Murase K., Hattori A., Kohno M., Hayashi K. Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int 1993; 30: 615-621.
  21. Packer L., Witt E.H., Tritschler H.J. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 2: 227-250.
  22. Packer L., Tritschler H.J., Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22: 359-378.
  23. Peltier A.C., Russell J.W. Advances in understanding drug-induced neuropathies. Drug Saf 2006; 29: 1: 23-30.
  24. Perricione N. The Wrinkle Cure, Chapter 6 "Alpha Lipoic Acid" 71-72. Warner Books 2000.
  25. Phase III Randomized Study of Alpha-Lipoic Acid in Preventing Platinum-Induced Peripheral Neuropathy in Cancer Patients Receiving a Cisplatin- or Oxaliplatin-Containing Chemotherapy Regimen (MDA-CCC-0327).
  26. Pirlich M., Kiok K., Sandig G. et al. Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells. Neurosci Lett 2002; 9: 328: 2: 93-96.
  27. Ranieri M., Sciuscio M., Cortese A.M. et al. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. Int J Immunopathol Pharmacol 2009; 22: 3 Suppl: 45-50.
  28. Reed L.J., DeBusk B.G., Gunsalus I.C., Hornberger C.S.Jr. Cristalline alpha-lipoic acid: a catalytic agent associated with pyruvate dehydrogenase. Science 1951; 114: 2952: 93-94.
  29. Reed L.J. The chemistry and function of lipoic acid. Adv Enzymol 1957; 18: 319-347.
  30. Ruhnau K.J., Meissner H.P., Finn J.R. et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 1999; 16: 1040-1043.
  31. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998; 55: 11: 1747-1758.
  32. Senoglu M., Nacitarhan V., Kurutas E.B. et al. Intraperitoneal Alpha-Lipoic Acid to prevent neural damage after crush injury to the rat sciatic nerve. J Brachial Plex Peripher Nerve Inj 2009; 4: 22.
  33. Snell E.E., Strong F.M., Peterson W.H. Growth factors for bacteria. VI: Fractionation and properties of an accessory factor for lactic acid bacteria. Biochem J 1937; 31: 10: 1789-1799.
  34. Teichert J., Preiss R. HPLC-methods for determination of lipoic acid and its reduced form in human plasma. Int J Clin Pharmacol Ther Toxicol 1992; 30: 511-512.
  35. Yadav V., Marracci G., Lovera J. et al. Lipoic acid in multiple sclerosis: a pilot study. Mult Scler 2005; 11: 159-165.
  36. Ziegler D., Hanefeld M., Ruhnau K.J. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296-1301.
  37. Ziegler D. Thioctic acid for patients with symptomatic diabetic neuropathy: a critical review. Treat Endocrinol 2004; 3: 3: 173-189.
  38. Ziegler D., Nowak H., Kempler P. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21: 2: 114-121.
  39. Ziegler D., Ametov A., Barinov A. et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy. The SYDNEY 2 trial. Diabetes Care 2006; 29: 2365-2370.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.